Shining on Major News: EV Energy Partners LP (NASDAQ:EVEP), Adaptimmune Therapeutics plc (NASDAQ:ADAP), Kandi Technologies Group, Inc. (NASDAQ:KNDI),

On 29 February, EV Energy Partners LP (NASDAQ:EVEP) announced results for the fourth quarter and full year 2015 and the filing of its Form 10-K with the Securities and Exchange Commission. In addition, EVEP announced its 2015 year-end proved reserves and 2016 guidance. Adjusted EBITDAX for the fourth quarter of 2015 was $52.7 million, a 5 percent decrease from the fourth quarter of 2014 and a 20 percent increase over the third quarter of 2015.

EV Energy Partners LP (NASDAQ:EVEP) belongs to Basic Materials sector. Its net profit margin is 64.40% and weekly performance is 35.20%. On last trading day company shares ended up at $2.42. EV Energy Partners LP (NASDAQ:EVEP) distance from 50-day simple moving average (SMA50) is -3.20%.

Adaptimmune Therapeutics plc (NASDAQ:ADAP) announced that James Noble, Chief Executive Officer of Adaptimmune, will present at Cowen and Company’s 36thAnnual Health Care Conference on Monday, March 7th at 4:40 PM (9:40 PM GMT). The conference is being held at the Boston Marriott Copley Place, in Boston, MA.

Adaptimmune Therapeutics plc (NASDAQ:ADAP) shares moved down -1.08% in last trading session and ended the day at $8.24. ADAP return on assets is -39.20%. Adaptimmune Therapeutics plc (NASDAQ:ADAP) quarterly performance is -16.85%.

Kandi Technologies Group, Inc. (NASDAQ:KNDI) announced that it will report fourth quarter and full year 2015 financial results on Monday, March 14, 2016, before the open of trading in the U.S.

On 04 March, Kandi Technologies Group, Inc. (NASDAQ:KNDI) shares increased 0.42% and was closed at $7.14. KNDI EPS growth in last 5 year was 42.10%. Kandi Technologies Group, Inc. (NASDAQ:KNDI) year to date (YTD) performance is -34.50%.

Pacific Drilling S.A. (NYSE:PACD) announced a net loss for fourth-quarter 2015 of $13.6 million or $0.06 per diluted share, compared to net income for third-quarter 2015 of $41.0 million or $0.19 per diluted share. Net income for fourth-quarter 2014 was $68.0 million or $0.32 per diluted share.

Pacific Drilling S.A. (NYSE:PACD) ended the last trading day at $0.82. Company weekly volatility is calculated as 31.67% and price to cash ratio as 1.17. Pacific Drilling S.A. (NYSE:PACD) showed a weekly performance of 90.70%.

On 2 March, RTI Surgical Inc. (NASDAQ:RTIX) applauds the appointment of Curtis M. Selquist as chairman of the board. Mr. Selquist represents Water Street Healthcare Partners, RTI’s largest investor.

RTI Surgical Inc. (NASDAQ:RTIX) shares increased 1.91% in last trading session and ended the day at $3.73. RTIX Gross Margin is 53.10% and its return on assets is 2.20%. RTI Surgical Inc. (NASDAQ:RTIX) quarterly performance is -12.24%.

Leave a Reply

Your email address will not be published. Required fields are marked *